Market research
HWH.AU Houston We Have Limited
AU AUD Software
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.01
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Software
- Industry
- Information Technology
- ISIN
- AU0000073439
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 1.01
About
About Houston We Have Limited
EchoIQ Limited provides cardiac diagnostics technology solution in Australia. The company's artificial intelligence-assisted diagnostics technology supports the sensitive diagnosis of Aortic Stenosis. It primarily serves device manufacturers, cardio scanning equipment, pharmaceuticals, and healthcare providers and insurers, as well as clinicians and patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. EchoIQ Limited is based in St Leonards, Australia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the HWH.AU discussion.
5 years, 5 months ago
Houston We Have Limited is currently in a long term uptrend where the price is trading 86.8% above its 200 day moving average.
From a valuation standpoint, the stock is 78.4% cheaper than other stocks from the Technology sector with a price to sales ratio of 15.4.
Houston We Have Limited's total revenue rose by 139.5% to $502K since the same quarter in the previous year.
Its net income has increased by 42.5% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 38.4% to $-346K since the same quarter in the previous year.
Based on the above factors, Houston We Have Limited gets an overall score of 5/5.